Global Device Approvals, Weekly Snapshot: FDA Approves Medtronic's Resolute Onyx, Resolute Integrity DES
Executive Summary
A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. Newly added devices include US FDA approval of Medtronic's Resolute Integrity and Resolute Onyx zotarolimus-eluting coronary stents, and agency approval and a CE mark for InSightec's ExAblate ultrasound device for treating tremor-dominant Parkinson's disease.